Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)

碩士 === 慈濟大學 === 神經科學研究所 === 94 === Recent studies have shown that trace fear conditioning (TFC) was hippocampal dependent. Mice were followed the trace fear conditioning to learn the connection between the conditioned stimulus (CS) and unconditioned stimulus (US) . Previous studies have shown that t...

Full description

Bibliographic Details
Main Authors: Shaw-nong Wang, 王少農
Other Authors: Ingrid Y.-C, Liu
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/03486999356750829366
id ndltd-TW-094TCU05291011
record_format oai_dc
spelling ndltd-TW-094TCU052910112016-06-01T04:21:13Z http://ndltd.ncl.edu.tw/handle/03486999356750829366 Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase) 連續K它命注射影響痕跡恐懼記憶及相關MAPK(Mitogen-activatedproteinkinase)表現之研究 Shaw-nong Wang 王少農 碩士 慈濟大學 神經科學研究所 94 Recent studies have shown that trace fear conditioning (TFC) was hippocampal dependent. Mice were followed the trace fear conditioning to learn the connection between the conditioned stimulus (CS) and unconditioned stimulus (US) . Previous studies have shown that the trace fear conditioning would evoke expression of learning and memory associated proteins, such us Erk (Extracellular Signal-Reagulated kinase). Ketamine is an NMDA receptor antagonist, it would block the NMDA receptor channel, supress Erk signaling and LTP formation, in turn cause memory defection. We suspect that repeated ketamine administration would influence the phosphorylation of Erk and p38 proteins. Therefore, We injected ketamine into mice that learned trace fear conditioning and investigated their freezing to cues and associated phosphorylation of Erk and p38. After the trace fear conditioning, mice received ketamine administration for 7 continuous days with different dosages (25 mg/kg, 50 mg/kg, 100 mg/kg), and then tested them on contextual and tone memory. We found that their freezing behavior was decreased to both contextual and tone test. In addition, Erk1 phosphorylation was decreased in the prefrontal cortex after tone test in 100 mg/kg group. In the hippocampus, Erk1 was also decresed in the 50 mg/kg group, but changes of p38 phosphorylation was not significant after both contextual test and tone test. Future works will focus on investigating changes of upstream and downstream molecules of Erk1 signaling after tone test to elucidate the underlying molecular mechanism of ketamine effect on retrieval of trace fear memory. Ingrid Y.-C, Liu 劉怡均 2006 學位論文 ; thesis 68 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 慈濟大學 === 神經科學研究所 === 94 === Recent studies have shown that trace fear conditioning (TFC) was hippocampal dependent. Mice were followed the trace fear conditioning to learn the connection between the conditioned stimulus (CS) and unconditioned stimulus (US) . Previous studies have shown that the trace fear conditioning would evoke expression of learning and memory associated proteins, such us Erk (Extracellular Signal-Reagulated kinase). Ketamine is an NMDA receptor antagonist, it would block the NMDA receptor channel, supress Erk signaling and LTP formation, in turn cause memory defection. We suspect that repeated ketamine administration would influence the phosphorylation of Erk and p38 proteins. Therefore, We injected ketamine into mice that learned trace fear conditioning and investigated their freezing to cues and associated phosphorylation of Erk and p38. After the trace fear conditioning, mice received ketamine administration for 7 continuous days with different dosages (25 mg/kg, 50 mg/kg, 100 mg/kg), and then tested them on contextual and tone memory. We found that their freezing behavior was decreased to both contextual and tone test. In addition, Erk1 phosphorylation was decreased in the prefrontal cortex after tone test in 100 mg/kg group. In the hippocampus, Erk1 was also decresed in the 50 mg/kg group, but changes of p38 phosphorylation was not significant after both contextual test and tone test. Future works will focus on investigating changes of upstream and downstream molecules of Erk1 signaling after tone test to elucidate the underlying molecular mechanism of ketamine effect on retrieval of trace fear memory.
author2 Ingrid Y.-C, Liu
author_facet Ingrid Y.-C, Liu
Shaw-nong Wang
王少農
author Shaw-nong Wang
王少農
spellingShingle Shaw-nong Wang
王少農
Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
author_sort Shaw-nong Wang
title Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
title_short Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
title_full Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
title_fullStr Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
title_full_unstemmed Effects of repeated ketamine administration on trace fear memory and associated expression of MAPK (Mitogen-activated protein kinase)
title_sort effects of repeated ketamine administration on trace fear memory and associated expression of mapk (mitogen-activated protein kinase)
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/03486999356750829366
work_keys_str_mv AT shawnongwang effectsofrepeatedketamineadministrationontracefearmemoryandassociatedexpressionofmapkmitogenactivatedproteinkinase
AT wángshǎonóng effectsofrepeatedketamineadministrationontracefearmemoryandassociatedexpressionofmapkmitogenactivatedproteinkinase
AT shawnongwang liánxùktāmìngzhùshèyǐngxiǎnghénjīkǒngjùjìyìjíxiāngguānmapkmitogenactivatedproteinkinasebiǎoxiànzhīyánjiū
AT wángshǎonóng liánxùktāmìngzhùshèyǐngxiǎnghénjīkǒngjùjìyìjíxiāngguānmapkmitogenactivatedproteinkinasebiǎoxiànzhīyánjiū
_version_ 1718290160975609856